Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 350

1.

'Threshold-crossing': A useful way to establish the counterfactual in clinical trials?

Eichler HG, Bloechl-Daum B, Bauer P, Bretz F, Brown J, Hampson LV, Honig P, Krams M, Leufkens H, Lim R, Lumpkin MM, Murphy MJ, Pignatti F, Posch M, Schneeweiss S, Trusheim M, Koenig F.

Clin Pharmacol Ther. 2016 Sep 21. doi: 10.1002/cpt.515. [Epub ahead of print]

PMID:
27650716
2.

Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision Making: Healthcare Databases with Rapid Cycle Analytics to Support Adaptive Biomedical Innovation.

Schneeweiss S, Eichler HG, Garcia-Altes A, Chinn C, Eggimann AV, Garner S, Goettsch W, Lim R, Löbker W, Martin D, Müller T, Park BJ, Platt R, Priddy S, Ruhl M, Spooner A, Vannieuwenhuyse B, Willke RJ.

Clin Pharmacol Ther. 2016 Sep 14. doi: 10.1002/cpt.512. [Epub ahead of print]

PMID:
27627027
3.

Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.

Gagne JJ, Han X, Hennessy S, Leonard CE, Chrischilles EA, Carnahan RM, Wang SV, Fuller C, Iyer A, Katcoff H, Woodworth TS, Archdeacon P, Meyer TE, Schneeweiss S, Toh S.

Clin Pharmacol Ther. 2016 Jul 14. doi: 10.1002/cpt.429. [Epub ahead of print]

PMID:
27416001
4.

Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.

Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Johnson MG, Marty FM, Nagel J, Najdzinowicz M, Saul M, Shoham S, Silveira FP, Varughese CA, Wilck M, Weatherby L, Auton T, Walker AM.

J Antimicrob Chemother. 2016 Oct;71(10):2938-44. doi: 10.1093/jac/dkw225. Epub 2016 Jul 12.

PMID:
27407049
5.

Concussion and its management: What do parents know?

Weerdenburg K, Schneeweiss S, Koo E, Boutis K.

Paediatr Child Health. 2016 Apr;21(3):e22-6.

PMID:
27398059
6.

New findings in HCV genotype distribution in selected West European, Russian and Israeli regions.

Kartashev V, Döring M, Nieto L, Coletta E, Kaiser R, Sierra S; HCV EuResist Study group.

J Clin Virol. 2016 Aug;81:82-9. doi: 10.1016/j.jcv.2016.05.010. Epub 2016 May 24.

7.

Complexity of Ultrasound and CT Fusion Examinations: Are They Feasible in the Daily Routine?

Esser M, Schneeweiss S, Nikolaou K, Horger M.

AJR Am J Roentgenol. 2016 Jun 24:1-6. [Epub ahead of print]

PMID:
27341549
8.

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.

Wang SV, Franklin JM, Glynn RJ, Schneeweiss S, Eddings W, Gagne JJ.

BMJ. 2016 May 24;353:i2607. doi: 10.1136/bmj.i2607.

9.

Relationship between Resilience, Psychological Distress and Physical Activity in Cancer Patients: A Cross-Sectional Observation Study.

Matzka M, Mayer H, Köck-Hódi S, Moses-Passini C, Dubey C, Jahn P, Schneeweiss S, Eicher M.

PLoS One. 2016 Apr 28;11(4):e0154496. doi: 10.1371/journal.pone.0154496. eCollection 2016.

10.

Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical data.

Kumamaru H, Schneeweiss S, Glynn RJ, Setoguchi S, Gagne JJ.

Emerg Themes Epidemiol. 2016 Apr 5;13:5. doi: 10.1186/s12982-016-0047-x. eCollection 2016.

11.

Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study.

Kim SC, Schneeweiss S, Liu J, Karlson EW, Katz JN, Feldman S, Solomon DH.

Arthritis Rheumatol. 2016 Sep;68(9):2106-13. doi: 10.1002/art.39689.

PMID:
27015113
12.

Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medications.

Kumamaru H, Gagne JJ, Glynn RJ, Setoguchi S, Schneeweiss S.

J Clin Epidemiol. 2016 Feb 27. pii: S0895-4356(16)00142-6. doi: 10.1016/j.jclinepi.2016.02.011. [Epub ahead of print]

PMID:
26931292
13.

Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.

Lin KJ, Schneeweiss S.

Clin Pharmacol Ther. 2016 Aug;100(2):147-59. doi: 10.1002/cpt.359. Epub 2016 May 12. Review.

PMID:
26916672
14.

Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.

Desai RJ, Solomon DH, Schneeweiss S, Danaei G, Liao KP, Kim SC.

Epidemiology. 2016 May;27(3):414-22. doi: 10.1097/EDE.0000000000000446.

PMID:
26808597
15.

Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data.

Gagne JJ, Bykov K, Najafzadeh M, Choudhry NK, Martin DP, Kahler KH, Rogers JR, Schneeweiss S.

Value Health. 2015 Dec;18(8):1063-9. doi: 10.1016/j.jval.2015.08.011. Epub 2015 Oct 21.

PMID:
26686792
16.

Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs: A Simulation Study.

Gagne JJ, Najafzadeh M, Choudhry NK, Bykov K, Kahler KH, Martin D, Rogers JR, Schneeweiss S.

Value Health. 2015 Dec;18(8):1057-62. doi: 10.1016/j.jval.2015.08.015. Epub 2015 Nov 2.

PMID:
26686791
17.

Improving therapeutic effectiveness and safety through big healthcare data.

Schneeweiss S.

Clin Pharmacol Ther. 2016 Mar;99(3):262-5. doi: 10.1002/cpt.316. Epub 2016 Jan 17.

PMID:
26659268
18.

Developing alerting thresholds for prospective drug safety monitoring.

Wangge G, Schneeweiss S, Glynn RJ, Gagne JJ.

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):755-62. doi: 10.1002/pds.3905. Epub 2015 Nov 24.

PMID:
26596260
19.

DECISION-MAKING ALIGNED WITH RAPID-CYCLE EVALUATION IN HEALTH CARE.

Schneeweiss S, Shrank WH, Ruhl M, Maclure M.

Int J Technol Assess Health Care. 2015 Jan;31(4):214-22. doi: 10.1017/S0266462315000410. Epub 2015 Nov 20.

PMID:
26585440
20.

A Practical Guide To Adding Patient Heterogeneity Into Phase Iii Trials: Results from Imi Getreal Wp2.

Karcher H, Fu S, Nordon C, Efthimiou O, Schneeweiss S, Abenhaim L.

Value Health. 2015 Nov;18(7):A727. doi: 10.1016/j.jval.2015.09.2766. Epub 2015 Oct 20. No abstract available.

PMID:
26534070
Items per page

Supplemental Content

Loading ...
Write to the Help Desk